Insulin Therapy Center

I was reviewing a client’s insulin administration. She was administering Levemir (insulin detemir), 60 units, with a FlexPen. She said that she just dialed the dose to the maximum it would allow her as she knew it only would dial to 60 units. She did not confirm the dose visually. Although …

Using a GLP-1 agonist with insulin may be the most effective therapy combination for lowering HbA1c in type 2 diabetes patients…. Researchers performed a systematic review and pooled meta-analysis of randomized controlled trials published between January 1, 1950 and July 29, 2014. Out of the 2,905 studies that were identified, …

Tresiba, in combination with insulin aspart, effectively improved long-term glycemic control….

The rate of nocturnal hypoglycemia was also significantly lower in patients taking BIL…. 

A reduced risk of nocturnal hypoglycemia is among the advantages…. 

BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction…. 

Basaglar (insulin glargine injection) by Lilly and Boehringer  The FDA has granted tentative approval for Basaglar (insulin glargine injection), a basal insulin. Basaglar is Eli Lilly and Co. and Boehringer Ingelheim"s basal insulin. Basaglar has the same amino acid sequence as the currently marketed insulin glargine product. While the FDA …

BIOD-531 is a new ultra-rapid-acting insulin formulation that has been shown to work better than current therapies at treating diabetes in a mid-stage trial…. 

Renal abnormalities may be indicated by a specific key marker in type 2 diabetes…. 

It is always interesting when you two legends in diabetes care sit down and have a conversation about the use of medications in patient care. Usually these thought leaders are early adopters when it comes to using medication combinations for diabetes. I had the opportunity to review a conversation that John …